06.12.2012 Views

1 Fuchs Endothelial Dystrophy

1 Fuchs Endothelial Dystrophy

1 Fuchs Endothelial Dystrophy

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

123. Nesburn AB, Burke RL, Ghiasi H, Slanina S, Bahri<br />

S, Wechsler SL (1994) Vaccine therapy for ocular<br />

herpes simplex virus (HSV) infection: periocular<br />

vaccination reduces spontaneous ocular HSV<br />

type 1 shedding in latently infected rabbits. J Virol<br />

68:5084–5092<br />

124. Nesburn AB, Burke RL, Ghiasi H, Slanina SM,<br />

Wechsler SL (1998) A therapeutic vaccine that<br />

reduces recurrent herpes simplex virus type<br />

1 corneal disease. Invest Ophthalmol Vis Sci<br />

39:1163–1170<br />

125. Nesburn AB, Slanina S, Burke RL, Ghiasi H, Bahri<br />

S, Wechsler SL (1998) Local periocular vaccination<br />

protects against eye disease more effectively<br />

than systemic vaccination following primary ocular<br />

herpes simplex virus infection in rabbits. J Virol<br />

72:7715–7721<br />

126. Nicholls SM, Shimeld C, Easty DL, Hill TJ (1996)<br />

Recurrent herpes simplex after corneal transplantation<br />

in rats. Invest Ophthalmol Vis Sci<br />

37:425–435<br />

127. Norberg P, Bergstrom T, Rekabdar E, Lindh M,<br />

Liljeqvist JA (2004) Phylogenetic analysis of clinical<br />

herpes simplex virus type 1 isolates identified<br />

three genetic groups and recombinant viruses. J<br />

Virol 78:10755–10764<br />

128. Norn MS (1970) Dendritic (herpetic) keratitis. I.<br />

Incidence – seasonal variations – recurrence rate<br />

– visual impairment – therapy. Acta Ophthalmol<br />

(Copenh) 48:91–107<br />

129. Norose K, Yano A, Zhang XM, Blankenhorn E,<br />

Heber-Katz E (2002) Mapping of genes involved<br />

in murine herpes simplex virus keratitis: identification<br />

of genes and their modifiers. J Virol<br />

76:3502–3510<br />

130. O’Brien WJ, Tsao LS, Taylor JL (1998) Tissuespecific<br />

accumulation of latency-associated transcripts<br />

in herpes virus-infected rabbits. Invest<br />

Ophthalmol Vis Sci 39:1847–1853<br />

131. Okuda T, Kurokawa M, Matsuo K, Honda M, Niimura<br />

M, Shiraki K (2004) Suppression of generation<br />

and replication of acyclovir-resistant herpes<br />

simplex virus by a sensitive virus. J Med Virol<br />

72:112–120<br />

132. Olsen TW, Hardten DR, Meiusi RS, Holland EJ<br />

(1994) Linear endotheliitis. Am J Ophthalmol<br />

117:468–474<br />

133. Oosterhuis JA, van GR, Versteeg J (1983) Acyclovir<br />

treatment in stromal herpetic keratitis. Doc<br />

Ophthalmol 56:81–88<br />

References 149<br />

134. Openshaw H, McNeill JI, Lin XH, Niland J, Cantin<br />

EM (1995) Herpes simplex virus DNA in normal<br />

corneas: persistence without viral shedding<br />

from ganglia. J Med Virol 46:75–80<br />

135. Osorio Y, Ghiasi H (2003) Comparison of adjuvant<br />

efficacy of herpes simplex virus type 1 recombinant<br />

viruses expressing TH1 and TH2 cytokine<br />

genes. J Virol 77:5774–5783<br />

136. Osorio Y, Ghiasi H (2005) Recombinant herpes<br />

simplex virus type 1 (HSV-1) codelivering interleukin-12p35<br />

as a molecular adjuvant enhances<br />

the protective immune response against ocular<br />

HSV-1 challenge. J Virol 79:3297–3308<br />

137. Osorio Y, Cohen J, Ghiasi H (2004) Improved protection<br />

from primary ocular HSV-1 infection and<br />

establishment of latency using multigenic DNA<br />

vaccines. Invest Ophthalmol Vis Sci 45:506–514<br />

138. Ostler HB (1976) Herpes simplex: the primary<br />

infection. Surv Ophthalmol 21:91–99<br />

139. Pavan-Langston D (1975) Diagnosis and management<br />

of herpes simplex ocular infection. Int Ophthalmol<br />

Clin 15:19–35<br />

140. Pavan-Langston D, Langston RH, Geary PA<br />

(1974) Prophylaxis and therapy of experimental<br />

ocular herpes simplex. Comparison of idoxuridine,<br />

adenine arabinoside, and hypoxanthine arabinoside.<br />

Arch Ophthalmol 92:417–421<br />

141. Peek R, Verjans GM, Meek B (2002) Herpes simplex<br />

virus infection of the human eye induces a<br />

compartmentalized virus-specific B cell response.<br />

J Infect Dis 186:1539–1546<br />

142. Penfold ME, Armati P, Cunningham AL (1994)<br />

Axonal transport of herpes simplex virions to<br />

epidermal cells: evidence for a specialized mode<br />

of virus transport and assembly. Proc Natl Acad<br />

Sci USA 91:6529–6533<br />

143. Pepose JS (1991) External ocular herpesvirus infections<br />

in immunodeficiency. Curr Eye Res 10<br />

[Suppl]:87–95<br />

144. Perng GC, Mott KR, Osorio N, Yukht A, Salina<br />

S, Nguyen QH, Nesburn AB, Wechsler SL (2002)<br />

Herpes simplex virus type 1 mutants containing<br />

the KOS strain ICP34.5 gene in place of the McKrae<br />

ICP34.5 gene have McKrae-like spontaneous<br />

reactivation but non-McKrae-like virulence. J<br />

Gen Virol 83:2933–2942<br />

145. Poirier RH (1980) Herpetic ocular infections of<br />

childhood. Arch Ophthalmol 98:704–706

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!